Your browser doesn't support javascript.
loading
Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice.
Meiser, Bettina; Kaur, Rajneesh; Morrow, April; Peate, Michelle; Wong, W K Tim; McPike, Emily; Cops, Elisa; Nichols, Cassandra; Austin, Rachel; Fine, Miriam; Thrupp, Letitia; Ward, Robyn; Macrae, Finlay; Hiller, Janet E; Trainer, Alison H; Mitchell, Gillian.
Afiliação
  • Meiser B; Psychosocial Research Group, Prince of Wales Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, 2052, Australia. b.meiser@unsw.edu.au.
  • Kaur R; Psychosocial Research Group, Prince of Wales Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, 2052, Australia.
  • Morrow A; Psychosocial Research Group, Prince of Wales Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, 2052, Australia.
  • Peate M; Psychosocial Research Group, Prince of Wales Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, 2052, Australia.
  • Wong WKT; Department of Obstetrics and Oncology, Royal Women's Hospital, University of Melbourne, Melbourne, Australia.
  • McPike E; Psychosocial Research Group, Prince of Wales Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, 2052, Australia.
  • Cops E; School of Social Sciences, UNSW Sydney, Sydney, Australia.
  • Nichols C; Psychosocial Research Group, Prince of Wales Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, 2052, Australia.
  • Austin R; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
  • Fine M; Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, Australia.
  • Thrupp L; Genetic Health Queensland, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
  • Ward R; Adult Genetics Unit, Royal Adelaide Hospital, Adelaide and School of Medicine, University of Adelaide, Adelaide, Australia.
  • Macrae F; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
  • Hiller JE; University of Queensland, Brisbane, Australia.
  • Trainer AH; University of Sydney, Faculty of Medicine and Health, Sydney, Australia.
  • Mitchell G; Department of Medicine, Royal Melbourne Hospital, Melbourne, Australia.
Hered Cancer Clin Pract ; 19(1): 24, 2021 Apr 09.
Article em En | MEDLINE | ID: mdl-33836815
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Hered Cancer Clin Pract Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Hered Cancer Clin Pract Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália